4
Changes in Ownership
Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001078
SVP, Chief Medical Officer acquired 1,714 shares (other)
From the SEC's structured data for this filing
Trades in this filing
Meyers Michael L. · SVP, Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-01-31 | Other acquisition : show line 1 in the form | +1,714 | $12.39 | $21,236 | 23,280 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-02-02 | Grant or award : show line 2 in the form Stock Options (Right to buy) | +17,350 | $15.79 | $273,957 | 17,350 | D |
Loading xslF345X03/primarydocument.xml…